Cargando…
Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk
INTRODUCTION: Breastmilk contains proteins and cells which have stem cell properties. The human breastmilk stem cell mimick mesenchymal stem cells and expresses pluripotency genes. The protein level of breastmilk is high in colostrum and gradually subsides in the first year of lactation. The mesench...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324926/ https://www.ncbi.nlm.nih.gov/pubmed/34354424 http://dx.doi.org/10.1016/j.sjbs.2021.04.034 |
_version_ | 1783731461974654976 |
---|---|
author | Widjaja, Sri Lilidjanti Salimo, Harsono Yulianto, Indah Soetrisno |
author_facet | Widjaja, Sri Lilidjanti Salimo, Harsono Yulianto, Indah Soetrisno |
author_sort | Widjaja, Sri Lilidjanti |
collection | PubMed |
description | INTRODUCTION: Breastmilk contains proteins and cells which have stem cell properties. The human breastmilk stem cell mimick mesenchymal stem cells and expresses pluripotency genes. The protein level of breastmilk is high in colostrum and gradually subsides in the first year of lactation. The mesenchymal stem cells from breastmilk can be an alternative source of stem cells that can potentially affect cardiovascular therapy. This study aimed to identify the proteomic analysis of secretome mesenchymal stem-like cells under hypoxia compared to non-hypoxia from human breastmilk stem cells. MATERIAL AND METHODS: The human breastmilk was collected from six healthy breastfeeding women and transported to the laboratory under aseptic conditions. The breastmilk cells were isolated then cultured. After 72 h, the human breastmilk stem cells reached confluence then cleaned up and isolated in serum-free media (spheroid) to allow serial passaging every 48 h. The acquisition stem cell was made with flow cytometry. The cells were divided into hBSC secretomes under hypoxia (A) and non-hypoxia (B) and analyzed for LC-MS to identify the peptide structure. RESULTS: The human breastmilk cells contained several mesenchymal stem-like cells in density 2.4 × 10(6) cell/mL for hypoxia and 2 × 10(6) cell/mL for non-hypoxia conditions. The human breastmilk stem cell surface markers derived from the third cell passage process were 93.77% for CD44, 98.69% for CD73, 88.45% for CD90, and 96.30% for CD105. The protein level of secretome mesenchymal stem -like cells under hypoxia was measured at 5.56 μg/mL and 4.28 μg/mL for non-hypoxia. The liquid chromatography-mass spectrometry analysis identified 130 and 59 peptides from hypoxia and non-hypoxia of the human breastmilk stem cell secretome sequentially. Some important proteomics structures were found in the hypoxic human breastmilk stem cell secretome, such as transforming growth factor-β, VE-cadherin, and caspase. CONCLUSION: The human breastmilk cells contain mesenchymal stem-like cells and a high concentration of CD44, CD73, CD90, and CD105 as surface markers at third passage culture. The hypoxic hBSC secretome produces a higher protein level compare to non-hypoxia. The transforming growth factor -β was found in the hypoxic hBSC secretome as a modulator of VEGF-mediated angiogenesis. |
format | Online Article Text |
id | pubmed-8324926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83249262021-08-04 Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk Widjaja, Sri Lilidjanti Salimo, Harsono Yulianto, Indah Soetrisno Saudi J Biol Sci Original Article INTRODUCTION: Breastmilk contains proteins and cells which have stem cell properties. The human breastmilk stem cell mimick mesenchymal stem cells and expresses pluripotency genes. The protein level of breastmilk is high in colostrum and gradually subsides in the first year of lactation. The mesenchymal stem cells from breastmilk can be an alternative source of stem cells that can potentially affect cardiovascular therapy. This study aimed to identify the proteomic analysis of secretome mesenchymal stem-like cells under hypoxia compared to non-hypoxia from human breastmilk stem cells. MATERIAL AND METHODS: The human breastmilk was collected from six healthy breastfeeding women and transported to the laboratory under aseptic conditions. The breastmilk cells were isolated then cultured. After 72 h, the human breastmilk stem cells reached confluence then cleaned up and isolated in serum-free media (spheroid) to allow serial passaging every 48 h. The acquisition stem cell was made with flow cytometry. The cells were divided into hBSC secretomes under hypoxia (A) and non-hypoxia (B) and analyzed for LC-MS to identify the peptide structure. RESULTS: The human breastmilk cells contained several mesenchymal stem-like cells in density 2.4 × 10(6) cell/mL for hypoxia and 2 × 10(6) cell/mL for non-hypoxia conditions. The human breastmilk stem cell surface markers derived from the third cell passage process were 93.77% for CD44, 98.69% for CD73, 88.45% for CD90, and 96.30% for CD105. The protein level of secretome mesenchymal stem -like cells under hypoxia was measured at 5.56 μg/mL and 4.28 μg/mL for non-hypoxia. The liquid chromatography-mass spectrometry analysis identified 130 and 59 peptides from hypoxia and non-hypoxia of the human breastmilk stem cell secretome sequentially. Some important proteomics structures were found in the hypoxic human breastmilk stem cell secretome, such as transforming growth factor-β, VE-cadherin, and caspase. CONCLUSION: The human breastmilk cells contain mesenchymal stem-like cells and a high concentration of CD44, CD73, CD90, and CD105 as surface markers at third passage culture. The hypoxic hBSC secretome produces a higher protein level compare to non-hypoxia. The transforming growth factor -β was found in the hypoxic hBSC secretome as a modulator of VEGF-mediated angiogenesis. Elsevier 2021-08 2021-04-20 /pmc/articles/PMC8324926/ /pubmed/34354424 http://dx.doi.org/10.1016/j.sjbs.2021.04.034 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Widjaja, Sri Lilidjanti Salimo, Harsono Yulianto, Indah Soetrisno Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk |
title | Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk |
title_full | Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk |
title_fullStr | Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk |
title_full_unstemmed | Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk |
title_short | Proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk |
title_sort | proteomic analysis of hypoxia and non-hypoxia secretome mesenchymal stem-like cells from human breastmilk |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324926/ https://www.ncbi.nlm.nih.gov/pubmed/34354424 http://dx.doi.org/10.1016/j.sjbs.2021.04.034 |
work_keys_str_mv | AT widjajasrililidjanti proteomicanalysisofhypoxiaandnonhypoxiasecretomemesenchymalstemlikecellsfromhumanbreastmilk AT salimoharsono proteomicanalysisofhypoxiaandnonhypoxiasecretomemesenchymalstemlikecellsfromhumanbreastmilk AT yuliantoindah proteomicanalysisofhypoxiaandnonhypoxiasecretomemesenchymalstemlikecellsfromhumanbreastmilk AT soetrisno proteomicanalysisofhypoxiaandnonhypoxiasecretomemesenchymalstemlikecellsfromhumanbreastmilk |